Comparing Acupuncture With Medication to Reduce Anxiety and Depression in China
ConditionAnxiety Depression
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorDuke Kunshan University
About this trial
The main objective of this study is to compare medication (usual care) with acupuncture (as a standalone comparator) to identify the most (cost)effective and environmentally sustainable intervention to reduce anxiety and mild to moderate depression in adults in China.
Eligibility criteria
Qualifiers
Chinese nationals 18 years old and above
No mental health treatment in the past 6 months
Depressive disorder (F30-F39)
Fear anxiety disorder (F40)
Disqualifiers
Serious cardiovascular, cerebrovascular, liver, kidney and other serious life-threatening primary diseases
Poorly controlled diabetes
There is a risk of suicide
Those with head trauma, loss of consciousness or severe mental disorders
Trial design
Treatments tested in this trial
- Selective serotonin reuptake inhibitor (SSRI)
- Acupuncture
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Duke Kunshan University
Lead sponsor
Kunshan Hospital of Traditional Chinese Medicine
Collaborator
Kunshan Mental Health Center
Collaborator
National Natural Science Foundation of China
Collaborator
Source ClinicalTrials.gov